Search research articles
Contact Us
Filters
Showing results (281-290 of 377) with videos related to
Page
of 38
Sort By:
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2022
Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice
Carolin Kitzberger, Rebekka Spellerberg, Yang Han, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Theranostics
|
January 2, 2025
CXCR4-directed endoradiotherapy with [<sup>177</sup>Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia
Krischan Braitsch, Theo Lorenzini, Maike Hefter, et al.
European Urology
|
December 15, 2020
Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy
Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 11, 2025
[<sup>68</sup>Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy
Stephan Beintner-Skawran, Andrei Gafita, Theo Lorenzini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
EJNMMI Research
|
May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
Carolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Page
of 38
Search research articles
Search
Showing results (281-290 of 377) with videos related to
Sort By:
Page
of 38
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2022
Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice
Carolin Kitzberger, Rebekka Spellerberg, Yang Han, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Theranostics
|
January 2, 2025
CXCR4-directed endoradiotherapy with [<sup>177</sup>Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia
Krischan Braitsch, Theo Lorenzini, Maike Hefter, et al.
European Urology
|
December 15, 2020
Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy
Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 11, 2025
[<sup>68</sup>Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy
Stephan Beintner-Skawran, Andrei Gafita, Theo Lorenzini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
EJNMMI Research
|
May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
Carolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Page
of 38